Status:
COMPLETED
One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The primary objective of this study is to evaluate efficacy of AZD1981 in uncontrolled asthmatic patients on maintenance inhaled glucocorticosteroids.
Eligibility Criteria
Inclusion
- Six months history of asthma
- Daily use of inhaled glucocorticosteroids
- FEV1 40-85% of predicted normal
- Reversibility; increase in FEV1 more than 12% and 200 mL post-bronchodilator
Exclusion
- Other clinically relevant disease or disorders
- History of smoking of more than 10 pack years
- Respiratory infection within 30 days
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
368 Patients enrolled
Trial Details
Trial ID
NCT00758589
Start Date
September 1 2008
End Date
July 1 2009
Last Update
February 26 2014
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Buenos Aires, Argentina, Argentina
2
Research Site
Quilmes, Buenos Aires, Argentina
3
Research Site
Santa Fe, Santa Fe Province, Argentina
4
Research Site
San Miguel de Tucumán, Tucumán Province, Argentina